Mediclinic (MEI:JSE) trading update; - Mediclinic to suspend its dividend. -ON REPORTED BASIS, FY20 REVENUE WAS UP AROUND 5.5% AND PRE-IFRS16 EBITDA WAS DOWN AROUND 2.5% (FY19 PRE-IFRS16: GBP493M) - FY PRE-IFRS16 EARNINGS PER SHARE IS EXPECTED TO BE AROUND 25 PENCE
